These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 16565378)

  • 1. TNF-alpha-induced optic nerve degeneration and nuclear factor-kappaB p65.
    Kitaoka Y; Kitaoka Y; Kwong JM; Ross-Cisneros FN; Wang J; Tsai RK; Sadun AA; Lam TT
    Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1448-57. PubMed ID: 16565378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NMDA-induced interleukin-1beta expression is mediated by nuclear factor-kappa B p65 in the retina.
    Kitaoka Y; Munemasa Y; Nakazawa T; Ueno S
    Brain Res; 2007 Apr; 1142():247-55. PubMed ID: 17320050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear factor-kappa B p65 in NMDA-induced retinal neurotoxicity.
    Kitaoka Y; Kumai T; Kitaoka Y; Lam TT; Munemasa Y; Isenoumi K; Motoki M; Kuribayashi K; Kogo J; Kobayashi S; Ueno S
    Brain Res Mol Brain Res; 2004 Nov; 131(1-2):8-16. PubMed ID: 15530647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Axonal protection by brain-derived neurotrophic factor associated with CREB phosphorylation in tumor necrosis factor-alpha-induced optic nerve degeneration.
    Fujino H; Kitaoka Y; Hayashi Y; Munemasa Y; Takeda H; Kumai T; Kobayashi S; Ueno S
    Acta Neuropathol; 2009 Jan; 117(1):75-84. PubMed ID: 18830614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Axonal and cell body protection by nicotinamide adenine dinucleotide in tumor necrosis factor-induced optic neuropathy.
    Kitaoka Y; Hayashi Y; Kumai T; Takeda H; Munemasa Y; Fujino H; Kitaoka Y; Ueno S; Sadun AA; Lam TT
    J Neuropathol Exp Neurol; 2009 Aug; 68(8):915-27. PubMed ID: 19606062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylglyoxal suppresses TNF-alpha-induced NF-kappaB activation by inhibiting NF-kappaB DNA-binding.
    Laga M; Cottyn A; Van Herreweghe F; Vanden Berghe W; Haegeman G; Van Oostveldt P; Vandekerckhove J; Vancompernolle K
    Biochem Pharmacol; 2007 Aug; 74(4):579-89. PubMed ID: 17617381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spatiotemporal characterization of optic nerve degeneration after chronic hypoperfusion in the rat.
    Chidlow G; Holman MC; Wood JP; Casson RJ
    Invest Ophthalmol Vis Sci; 2010 Mar; 51(3):1483-97. PubMed ID: 19875659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Axonal protection via modulation of the amyloidogenic pathway in tumor necrosis factor-induced optic neuropathy.
    Kojima K; Kitaoka Y; Munemasa Y; Ueno S
    Invest Ophthalmol Vis Sci; 2012 Nov; 53(12):7675-83. PubMed ID: 23111606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear factor-κB/p65 responds to changes in the Notch signaling pathway in murine BV-2 cells and in amoeboid microglia in postnatal rats treated with the γ-secretase complex blocker DAPT.
    Cao Q; Li P; Lu J; Dheen ST; Kaur C; Ling EA
    J Neurosci Res; 2010 Sep; 88(12):2701-14. PubMed ID: 20648656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Axonal protection by 17β-estradiol through thioredoxin-1 in tumor necrosis factor-induced optic neuropathy.
    Kitaoka Y; Munemasa Y; Hayashi Y; Kuribayashi J; Koseki N; Kojima K; Kumai T; Ueno S
    Endocrinology; 2011 Jul; 152(7):2775-85. PubMed ID: 21586560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein kinase Cdelta activates RelA/p65 and nuclear factor-kappaB signaling in response to tumor necrosis factor-alpha.
    Lu ZG; Liu H; Yamaguchi T; Miki Y; Yoshida K
    Cancer Res; 2009 Jul; 69(14):5927-35. PubMed ID: 19549902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptide YY attenuates transcription factor activity in tumor necrosis factor-alpha-induced pancreatitis.
    Vona-Davis L; Yu A; Magabo K; Evans T; Jackson B; Riggs D; McFadden D
    J Am Coll Surg; 2004 Jul; 199(1):87-95. PubMed ID: 15217635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of protective effect of local administration of triamcinolone or systemic treatment with methylprednisolone against damages caused by optic nerve crush in rats.
    Huang TL; Chang CH; Lin KH; Sheu MM; Tsai RK
    Exp Eye Res; 2011 Feb; 92(2):112-9. PubMed ID: 21185832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of cytokine responses to retinal detachment in rats.
    Nakazawa T; Matsubara A; Noda K; Hisatomi T; She H; Skondra D; Miyahara S; Sobrin L; Thomas KL; Chen DF; Grosskreutz CL; Hafezi-Moghadam A; Miller JW
    Mol Vis; 2006 Aug; 12():867-78. PubMed ID: 16917487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased nuclear factor-kappa B p65 immunoreactivity following retinal ischemia and reperfusion injury in mice.
    Chen YG; Zhang C; Chiang SK; Wu T; Tso MO
    J Neurosci Res; 2003 Apr; 72(1):125-31. PubMed ID: 12645086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotective effects of recombinant human granulocyte colony-stimulating factor (G-CSF) in neurodegeneration after optic nerve crush in rats.
    Tsai RK; Chang CH; Wang HZ
    Exp Eye Res; 2008 Sep; 87(3):242-50. PubMed ID: 18602391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NF-kappaB activation in light-induced retinal degeneration in a mouse model.
    Wu T; Chen Y; Chiang SK; Tso MO
    Invest Ophthalmol Vis Sci; 2002 Sep; 43(9):2834-40. PubMed ID: 12202499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-related neural degeneration in nuclear-factor kappaB p50 knockout mice.
    Lu ZY; Yu SP; Wei JF; Wei L
    Neuroscience; 2006; 139(3):965-78. PubMed ID: 16533569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Slow axonal protein transport and visual function following retinal and optic nerve ischemia.
    Levy NS; Adams CK
    Invest Ophthalmol; 1975 Feb; 14(2):91-7. PubMed ID: 46218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinal-cell-conditioned medium prevents TNF-alpha-induced apoptosis of purified ganglion cells.
    Fuchs C; Forster V; Balse E; Sahel JA; Picaud S; Tessier LH
    Invest Ophthalmol Vis Sci; 2005 Aug; 46(8):2983-91. PubMed ID: 16043875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.